pindolol has been researched along with buspirone in 65 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (7.69) | 18.7374 |
1990's | 39 (60.00) | 18.2507 |
2000's | 14 (21.54) | 29.6817 |
2010's | 7 (10.77) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glennon, RA | 1 |
Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
Chaput, C; Millan, MJ; Newman-Tancredi, A; Verrièle, L | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Shibata, S; Tominaga, K; Ueki, S; Watanabe, S | 1 |
Buisson-Defferier, S; Van den Buuse, M | 1 |
Gilbert, F; Pan, L | 1 |
Newman-Tancredi, A; Strange, PG; Sundaram, H | 1 |
Lee, HS; Meltzer, HY; Nash, JF | 1 |
Anderson, IM; Cowen, PJ | 1 |
Kostowski, W; Pałejko, W; Płaźnik, A; Stefański, R | 1 |
Janowsky, DS; Overstreet, DH; Rezvani, AH | 1 |
Futuro-Neto, HA; Pires, JG; Silva, SR | 1 |
Eison, AS; Margraf, RR; Wright, RN; Yocca, FD | 1 |
Kalkman, HO; Soar, J | 1 |
Coccaro, EF; Gabriel, S; Macaluso, J; Mahon, T; Siever, LJ | 1 |
Coccaro, EF; Gabriel, S; Siever, LJ | 1 |
Cornfield, LJ; Martin, AR; Nelson, DL; Taylor, EW | 1 |
Rodgers, RJ; Shepherd, JK | 1 |
Fozard, JR; Kidd, EJ; Neill, J; Tricklebank, MD | 1 |
Brazell, C; Gilbert, F; Stahl, SM; Tricklebank, MD | 1 |
Bianchetti, A; Croci, T; Landi, M; Manara, L | 1 |
McNaughton, N; Zhu, XO | 1 |
Howland, RH | 1 |
Bramwell, S; Hjorth, S; McQuade, R; Sharp, T | 1 |
Carli, M; Grondin, L; Nénonéné, EK; Radja, F; Reader, TA | 1 |
Futuro-Neto, HA; Pires, JG; Ramage, AG; Silva, SR | 1 |
Kaneto, H; Takahashi, M; Tokuyama, S | 1 |
Jantos, H; Monti, JM; Reyes-Parada, M; Scorza, C; Silveira, R | 1 |
Bobadilla, RA; Castillo, C; Castillo, EF; Hong, E; Ibarra, M | 1 |
Bergeron, R; Blier, P | 1 |
Hjorth, S | 1 |
Horisaka, K; Kimura, I; Sugimoto, Y; Yamada, J | 1 |
Matos, FF; Urban, C; Yocca, FD | 1 |
Bergeron, R; Blier, P; de Montigny, C | 1 |
Herremans, AH; Mos, J; Olivier, B; Van Drimmelen, M; Van Hest, A | 1 |
Leander, JD; Wolff, MC | 1 |
Farde, L; Ginovart, N; Halldin, C; Ito, H; Lundkvist, C; McCarron, JA; Pike, VW | 1 |
Joffe, RT; Sussman, N | 2 |
Friedman, ES; Howland, RH; Thase, ME | 1 |
Nelson, JC | 2 |
Cadieux, RJ | 1 |
Cappellini, C; Costa, B; Malatesta, P; Marracci, S; Martini, C; Nardi, I | 1 |
Ishikawa, K; Kasamo, K; Kojima, T; Suzuki, T; Tada, K; Ueda, N | 1 |
Fava, M | 1 |
Passchier, J; Pieterman, RM; Vaalburg, W; van Waarde, A; Willemsen, AT | 1 |
Bridge, MW; Jones, DA; Kendall, MJ; Marvin, G; Sharma, A; Thompson, CE | 1 |
Estrada-Camarena, E; López-Rubalcava, C; Martínez-Mota, L | 1 |
Massey, AE; McAllister-Williams, RH | 1 |
Bridge, MW; Jones, DA; Rayson, M; Weller, AS | 1 |
Chen, R; Hamilton, R; Jordan, S; Kikuchi, T; Koprivica, V; Tottori, K; Whitehead, RE | 1 |
Carvalho, AF; Castelo, MS; Cavalcante, JL; Lima, MC | 1 |
Diwan, M; Hamani, C; Laver, B; Nobrega, JN | 1 |
Berrocoso, E; González-Saiz, F; Mico, JA; Perez-Caballero, L; Romero-López-Alberca, C; Torres-Sanchez, S | 1 |
9 review(s) available for pindolol and buspirone
Article | Year |
---|---|
Central serotonin receptors as targets for drug research.
Topics: Animals; Humans; Receptors, Serotonin; Research Design; Serotonin | 1987 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treating antidepressant nonresponders with augmentation strategies: an overview.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Lithium; Pindolol; Severity of Illness Index; Thyroid Hormones; Treatment Outcome | 1998 |
Overcoming treatment resistance in depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Lithium; Pindolol; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triiodothyronine | 1998 |
Practical management of treatment-resistant depression.
Topics: Antidepressive Agents; Buspirone; Depression; Drug Resistance; Drug Therapy, Combination; Humans; Lithium; Pindolol; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Triiodothyronine | 1998 |
New approaches to the treatment of refractory depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Pindolol; Piperazines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thyroxine; Triazoles; Triiodothyronine | 2000 |
Augmentation strategies in depression 2000.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Buspirone; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Monoamine Oxidase Inhibitors; Pindolol; Selective Serotonin Reuptake Inhibitors; Triiodothyronine; Tryptophan | 2000 |
Augmentation strategies for treatment-resistant depression: a literature review.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Buspirone; Central Nervous System Stimulants; Depressive Disorder; Dopamine Agents; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Lithium Compounds; Pindolol; Triiodothyronine | 2007 |
Monoaminergic system and depression.
Topics: Antidepressive Agents; Antipsychotic Agents; Biogenic Monoamines; Buspirone; Depressive Disorder, Major; Drug Synergism; Excitatory Amino Acid Agents; Humans; Lithium; Pindolol; Triiodothyronine | 2019 |
5 trial(s) available for pindolol and buspirone
Article | Year |
---|---|
Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers.
Topics: Adult; Body Temperature; Buspirone; Growth Hormone; Humans; Male; Pindolol; Prolactin; Receptors, Serotonin | 1992 |
Preliminary evidence of a serotonin (5-HT-1-like) component to the prolactin response to buspirone challenge in humans.
Topics: Adrenocorticotropic Hormone; Adult; Buspirone; Cortisone; Growth Hormone; Humans; Male; Metergoline; Pindolol; Prolactin; Receptors, Dopamine; Receptors, Serotonin | 1990 |
Quantifying the 5-HT1A agonist action of buspirone in man.
Topics: Adolescent; Adult; Area Under Curve; Buspirone; Cross-Over Studies; Humans; Male; Pindolol; Prolactin; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists; Single-Blind Method; Statistics, Nonparametric | 2001 |
EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Body Temperature; Buspirone; Cross-Over Studies; Double-Blind Method; Electroencephalography; Excitatory Postsynaptic Potentials; Human Growth Hormone; Humans; Male; Pindolol; Prolactin; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists | 2003 |
Responses to exercise in the heat related to measures of hypothalamic serotonergic and dopaminergic function.
Topics: Adaptation, Physiological; Adult; Blood Glucose; Body Temperature Regulation; Buspirone; Exercise; Exercise Test; Exercise Tolerance; Hot Temperature; Humans; Hypothalamus; Lactic Acid; Male; Oxygen Consumption; Physical Endurance; Pindolol; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Antagonists; Skin Temperature; Sweating | 2003 |
51 other study(ies) available for pindolol and buspirone
Article | Year |
---|---|
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Affinity Labels; Animals; Binding, Competitive; CHO Cells; Cricetinae; Guanine Nucleotides; Hippocampus; Humans; Male; Membranes; Piperazines; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists | 1998 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physical binding pocket induction for affinity prediction.
Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Effects of 5-HT1A receptor agonists on the circadian rhythm of wheel-running activity in hamsters.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Circadian Rhythm; Cricetinae; Male; Melatonin; Mesocricetus; Motor Activity; Pindolol; Piperazines; Receptors, GABA-A; Receptors, Serotonin; Tetrahydronaphthalenes | 1992 |
Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Buspirone; Dioxins; Heart Rate; Hypertension; Male; Pindolol; Piperazines; Rats; Rats, Inbred SHR; Receptors, Serotonin; Serotonin Receptor Agonists; Spiro Compounds; Vasodilator Agents | 1992 |
Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Animals; Buspirone; Corticotropin-Releasing Hormone; Male; Paraventricular Hypothalamic Nucleus; Pindolol; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Receptor Agonists | 1992 |
Pharmacological characterisation of the 5-HT1A serotonin receptor using the agonist [3H]8-OH-DPAT, and the antagonist [3H]spiperone.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; CHO Cells; Cricetinae; Humans; Kinetics; Lisuride; Methiothepin; Pindolol; Receptors, Serotonin; Recombinant Proteins; Serotonin; Serotonin Antagonists; Spiperone; Transfection; Tritium | 1992 |
Effect of buspirone on prolactin secretion is not mediated by 5-HT-1a receptor stimulation.
Topics: Buspirone; Dose-Response Relationship, Drug; Humans; Hydrocortisone; Pindolol; Prolactin; Receptors, Serotonin; Reproducibility of Results; Research Design | 1992 |
Serotonergic mechanisms in the nucleus accumbens affected by chronic desipramine treatment.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Buspirone; Chromans; Desipramine; Dose-Response Relationship, Drug; Methysergide; Microinjections; Nucleus Accumbens; Pindolol; Quipazine; Rats; Serotonin; Serotonin Antagonists; Tetrahydronaphthalenes | 1991 |
Drug-induced reductions in ethanol intake in alcohol preferring and Fawn-Hooded rats.
Topics: Alcohol Drinking; Alcoholism; Animals; Buspirone; Drinking Behavior; Ethanol; Feeding Behavior; Fluoxetine; Male; Pindolol; Piperazines; Rats; Rats, Inbred Strains; Rats, Wistar; Scopolamine; Self Administration; Serotonin Receptor Agonists; Species Specificity; Verapamil | 1991 |
Inhibition of chlorpromazine-induced catalepsy by the 5-HT-1A ligands pindolol and buspirone in mice.
Topics: Animals; Buspirone; Catalepsy; Chlorpromazine; Clomipramine; Female; Haloperidol; Male; Mice; Pindolol; Receptors, Serotonin | 1990 |
8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Head; Ketanserin; Male; Naphthalenes; Pindolol; Pyrimidines; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Stereotyped Behavior; Tetrahydronaphthalenes | 1990 |
Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Dioxanes; Haloperidol; Male; Motor Activity; Pindolol; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Spiro Compounds; Tetrahydronaphthalenes | 1990 |
Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans.
Topics: Adult; Aggression; Buspirone; Female; Humans; Male; Metergoline; Personality Disorders; Pindolol; Prolactin; Receptors, Serotonin | 1990 |
MDL 73005EF: partial agonist at the 5-HT1A receptor negatively linked to adenylate cyclase.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adenosine Triphosphate; Adenylyl Cyclase Inhibitors; Animals; Buspirone; Colforsin; Cyclic AMP; Dioxins; Hippocampus; In Vitro Techniques; Male; Membranes; Pindolol; Rats; Rats, Inbred Strains; Receptors, Serotonin; Spiro Compounds; Tetrahydronaphthalenes; Tryptamines | 1989 |
Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone.
Topics: Analgesia; Animals; Anti-Anxiety Agents; Buspirone; Male; Mice; Mice, Inbred DBA; Nociceptors; Pindolol; Pyrimidines; Reaction Time; Social Behavior | 1989 |
Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Alprenolol; Animals; Buspirone; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Psychological; Male; Naphthalenes; Pindolol; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Tetrahydronaphthalenes | 1987 |
Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Animals; Anti-Anxiety Agents; Buspirone; Male; Physostigmine; Pindolol; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Tetrahydronaphthalenes | 1988 |
Drug-induced defaecation in rats: role of central 5-HT1A receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Binding Sites; Buspirone; Colon; Defecation; Feces; Fenclonine; Male; Naphthalenes; Pindolol; Pyridines; Rats; Receptors, Serotonin; Serotonin Receptor Agonists; Time Factors | 1995 |
The interaction of serotonin depletion with anxiolytics and antidepressants on reticular-elicited hippocampal RSA.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Buspirone; Cytidine Diphosphate; Drug Interactions; Electric Stimulation; Electroencephalography; Hippocampus; Imipramine; Male; Pindolol; Rats; Rats, Sprague-Dawley; Reticular Formation; Serotonin; Theta Rhythm | 1994 |
Biochemical effects of antidepressant augmentation.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Humans; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 1995 |
Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Brain Chemistry; Buspirone; Dose-Response Relationship, Drug; Electrodes, Implanted; Electrophysiology; Hippocampus; Male; Microdialysis; Pindolol; Pyrimidines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Receptor Agonists | 1993 |
Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Binding, Competitive; Biogenic Amines; Buspirone; Cell Membrane; Cerebral Cortex; Fenclonine; Guanylyl Imidodiphosphate; Hippocampus; Kinetics; Male; Organ Specificity; p-Chloroamphetamine; Pindolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1994 |
Effects of the 5-HT receptor antagonists cyanopindolol, ICI 169,369, cisapride and granisetron on neuroleptic-induced catalepsy in mice.
Topics: Animals; Buspirone; Catalepsy; Cisapride; Female; Granisetron; Haloperidol; Male; Mice; Pindolol; Piperidines; Quinolines; Serotonin Antagonists; Time Factors | 1993 |
Involvement of serotonergic receptor subtypes in the production of antinociception by psychological stress in mice.
Topics: Animals; Buspirone; Dose-Response Relationship, Drug; Drug Tolerance; Male; Mice; Morphine; Pain; Pindolol; Receptors, Serotonin; Serotonin Antagonists; Stress, Psychological | 1993 |
Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone.
Topics: 5,7-Dihydroxytryptamine; Adrenergic beta-Antagonists; Animals; Biogenic Monoamines; Brain Chemistry; Buspirone; Dose-Response Relationship, Drug; Male; Pindolol; Pyrimidines; Rats; Rats, Wistar; Serotonin Agents; Serotonin Receptor Agonists; Sleep; Sleep, REM; Wakefulness | 1995 |
A comparative study of the effects of some 5-HT1A receptor agonists on the blood pressure of pithed rats.
Topics: 5-Methoxytryptamine; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Buspirone; Decerebrate State; Ketanserin; Male; Methoxamine; Pindolol; Prazosin; Pyrimidines; Quipazine; Rats; Rats, Wistar; Serotonin Receptor Agonists | 1995 |
Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorder: preliminary findings.
Topics: Adrenergic beta-Antagonists; Adult; Buspirone; Depression; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Obsessive-Compulsive Disorder; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Tryptophan | 1996 |
(-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine.
Topics: Animals; Buspirone; Citalopram; Drug Synergism; Hippocampus; Male; Pindolol; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists | 1996 |
The effects of the serotonin1A receptor agonist buspirone on tolbutamide-induced hypoglycemia in rats.
Topics: Animals; Blood Glucose; Buspirone; Epinephrine; Hypoglycemic Agents; Insulin; Male; Pindolol; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Tolbutamide | 1995 |
Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release.
Topics: Adrenergic beta-Antagonists; Animals; Buspirone; Dendrites; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Nerve Endings; Pindolol; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Receptor Agonists; Tetrodotoxin | 1996 |
Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Buspirone; Depressive Disorder; Desipramine; Drug Synergism; Female; Fluvoxamine; Humans; Male; Pindolol; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Trimipramine | 1997 |
The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Columbidae; Discrimination Learning; Fluvoxamine; Indoles; Pindolol; Piperazines; Pyridines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 1997 |
Differentiation of 5-HT1A receptor ligands by drug discrimination.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aminopyridines; Animals; Behavior, Animal; Buspirone; Columbidae; Cyclohexylamines; Discrimination Learning; Dose-Response Relationship, Drug; Idazoxan; Ligands; Male; Pindolol; Piperazines; Pyridines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain; Buspirone; Carbon Radioisotopes; Cerebellum; Macaca fascicularis; Male; Neocortex; Pindolol; Piperazines; Pyridines; Raphe Nuclei; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Tomography, Emission-Computed | 1997 |
Introduction: augmentation of antidepressant medication.
Topics: Anticonvulsants; Antidepressive Agents; Buspirone; Calcium Channel Blockers; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Humans; Lithium; Pindolol; Thyroid Hormones; Treatment Outcome | 1998 |
Antidepressant augmentation: conclusions and recommendations.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Buspirone; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Humans; Lithium; Pindolol; Triiodothyronine | 1998 |
Characterization of a cloned xenopus laevis serotonin 5-HT1A receptor expressed in the NIH-3T3 cell line.
Topics: 3T3 Cells; Animals; Buspirone; Cell Division; Cloning, Molecular; Gene Expression Regulation; Ketanserin; Mice; Pindolol; Receptors, Serotonin; Serotonin; Xenopus laevis | 1999 |
Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.
Topics: Animals; Anti-Anxiety Agents; Buspirone; Drug Interactions; Male; Neurons; Pindolol; Piperazines; Pyramidal Cells; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists | 1999 |
Quantifying drug-related 5-HT1A receptor occupancy with.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Brain Chemistry; Buspirone; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pindolol; Piperazines; Pyridines; Radiopharmaceuticals; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Tomography, Emission-Computed | 2001 |
Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
Topics: 5-Methoxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Buspirone; Dose-Response Relationship, Drug; Drug Interactions; Ketanserin; Male; Motor Activity; Pindolol; Pyridines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 2002 |
In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Autoradiography; Binding, Competitive; Buspirone; Cell Membrane; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Frontal Lobe; Guanosine 5'-O-(3-Thiotriphosphate); Hippocampus; Humans; Male; Middle Aged; Pindolol; Piperazines; Pyridines; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfur Radioisotopes | 2005 |
Augmentative therapies do not potentiate the antidepressant-like effects of deep brain stimulation in rats.
Topics: Animals; Behavior, Animal; Buspirone; Deep Brain Stimulation; Depression; Dopamine Antagonists; Gyrus Cinguli; Male; Pindolol; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Risperidone | 2014 |